Author:
Dutra Luiz A.,Lacerda Mariella G.,Destro Inácio Maiara,Martins Johnny W.L.,Lopes Silva Ana C.,Bento da Silva Patricia,Chorilli Marlus,Amato Angélica A.,Baviera Amanda M.,Passarelli Marisa,Guido Rafael V.C.,Dos Santos Jean L.
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference65 articles.
1. PPARs: Therapeutic targets for metabolic disease;Berger;Trends Pharmacol. Sci.,2005
2. Regulation of macrophage functions by PPAR- α, PPAR- γ, and LXRs in mice and men;Rigamonti;Arterioscler. Thromb. Vasc. Biol.,2008
3. PPARα, but not PPARγ, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia;Hennuyer;Arterioscler. Thromb. Vasc. Biol.,2005
4. HDL-targeted therapies: Progress, failures and future;Kingwell;Nat. Rev. Drug Discov.,2014
5. The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome;Tian;PLoS ONE,2014